Viemed Healthcare (VMD) Competitors

CareDx (NASDAQ:CDNA) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability.

Do insiders and institutionals hold more shares of CDNA or VMD?

74.2% of Viemed Healthcare shares are owned by institutional investors. 4.9% of CareDx shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Is CDNA or VMD more profitable?

Viemed Healthcare has a net margin of 4.87% compared to CareDx's net margin of -45.90%. Viemed Healthcare's return on equity of 8.72% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-45.90%	-53.70%	-30.42%
Viemed Healthcare	4.87%	8.72%	6.48%

Does the media refer more to CDNA or VMD?

In the previous week, CareDx had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for CareDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.71 beat CareDx's score of 1.66 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Viemed Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community favor CDNA or VMD?

CareDx received 439 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 65.87% of users gave CareDx an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.

Company	Underperform	Outperform
CareDx	Outperform Votes 442 65.87%	Underperform Votes 229 34.13%
Viemed Healthcare	Outperform Votes 3 42.86%	Underperform Votes 4 57.14%

Which has more volatility & risk, CDNA or VMD?

CareDx has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.

Do analysts rate CDNA or VMD?

CareDx presently has a consensus target price of $31.83, suggesting a potential upside of 74.62%. Given CareDx's higher possible upside, analysts clearly believe CareDx is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57
Viemed Healthcare	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Which has higher valuation and earnings, CDNA or VMD?

Viemed Healthcare has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$333.79M	3.03	-$190.28M	$1.02	17.87
Viemed Healthcare	$224.26M	1.27	$10.24M	$0.28	25.71

Summary

Viemed Healthcare beats CareDx on 10 of the 19 factors compared between the two stocks.